{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:30:51Z","timestamp":1780342251190,"version":"3.54.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,4,23]],"date-time":"2004-04-23T00:00:00Z","timestamp":1082678400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1038\/sj.eye.6701395","type":"journal-article","created":{"date-parts":[[2004,4,23]],"date-time":"2004-04-23T09:25:27Z","timestamp":1082712327000},"page":"65-71","source":"Crossref","is-referenced-by-count":112,"title":["Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide"],"prefix":"10.1038","volume":"19","author":[{"given":"J B","family":"Jonas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Akkoyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Kamppeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Kreissig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R F","family":"Degenring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,4,23]]},"reference":[{"key":"BF6701395_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0002-9394(01)01010-8","volume":"132","author":"JB Jonas","year":"2001","unstructured":"Jonas JB, S\u00f6fker A . Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular oedema. Am J Ophthalmol 2001; 132: 425\u2013427.","journal-title":"Am J Ophthalmol"},{"key":"BF6701395_CR2","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/S0161-6420(02)00975-2","volume":"109","author":"A Martidis","year":"2002","unstructured":"Martidis A, Duker JS, Greenberg PB, Rogers AH, Puliafito CA, Reichel E et al. Intravitreal triamcinolone for refractory diabetic macular oedema. Ophthalmology 2002; 109: 920\u2013927.","journal-title":"Ophthalmology"},{"key":"BF6701395_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/archopht.121.1.57","volume":"121","author":"JB Jonas","year":"2003","unstructured":"Jonas JB, Kreissig I, S\u00f6fker A, Degenring RF . Intravitreal injection of triamcinolone acetonide for diabetic macular oedema. Arch Ophthalmol 2003; 121: 57\u201361.","journal-title":"Arch Ophthalmol"},{"key":"BF6701395_CR4","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0002-9394(00)00882-5","volume":"131","author":"JB Jonas","year":"2001","unstructured":"Jonas JB, Hayler JK, S\u00f6fker A, Panda-Jonas S . Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative diabetic retinopathy. Am J Ophthalmol 2001; 131: 468\u2013471.","journal-title":"Am J Ophthalmol"},{"key":"BF6701395_CR5","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/00061198-200108000-00007","volume":"10","author":"JB Jonas","year":"2001","unstructured":"Jonas JB, Hayler JK, S\u00f6fker A, Panda-Jonas S . Regression of neovascular iris vessels by intravitreal injection of crystalline cortisone. J Glaucoma 2001; 10: 284\u2013287.","journal-title":"J Glaucoma"},{"key":"BF6701395_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/bjo.86.2.247","volume":"86","author":"PB Greenberg","year":"2002","unstructured":"Greenberg PB, Martidis A, Rogers AH, Duker JS, Reichel E . Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 2002; 86: 247\u2013248.","journal-title":"Br J Ophthalmol"},{"key":"BF6701395_CR7","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1007\/s00417-002-0529-0","volume":"240","author":"JB Jonas","year":"2002","unstructured":"Jonas JB, Kreissig I, Degenring RF . Intravitreal triamcinolone acetonide as treatment of macular oedema in central retinal vein occlusion. Graef Arch Clin Exp Ophthalmol 2002; 240: 782\u2013783.","journal-title":"Graef Arch Clin Exp Ophthalmol"},{"key":"BF6701395_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0002-9394(03)00228-9","volume":"136","author":"CH Park","year":"2003","unstructured":"Park CH, Jaffe GJ, Fekrat S . Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal veinocclusion. Am J Ophthalmol 2003; 136: 419\u2013425.","journal-title":"Am J Ophthalmol"},{"key":"BF6701395_CR9","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1136\/bjo.84.9.1064","volume":"84","author":"JB Jonas","year":"2000","unstructured":"Jonas JB, Hayler JK, Panda-Jonas S . Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol 2000; 84: 1064\u20131067.","journal-title":"Br J Ophthalmol"},{"key":"BF6701395_CR10","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s004170100293","volume":"239","author":"JB Jonas","year":"2001","unstructured":"Jonas JB, Hayler JK, Panda-Jonas S . Intravitreal injection of crystalline cortisone as treatment of pre-phthisical ocular hypotony. Graef Arch Clin Exp Ophthalmol 2001; 239: 464\u2013465.","journal-title":"Graef Arch Clin Exp Ophthalmol"},{"key":"BF6701395_CR11","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0161-6420(00)00658-8","volume":"108","author":"RJ Antcliff","year":"2001","unstructured":"Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, ffytche TJ, Marshall J . Intravitreal triamcinolone for uveitic cystoid macular oedema: an optical coherence tomography study. Ophthalmology 2001; 108: 765\u2013772.","journal-title":"Ophthalmology"},{"key":"BF6701395_CR12","first-page":"1380","volume":"119","author":"A Martidis","year":"2001","unstructured":"Martidis A, Duker JS, Puliafito CA . Intravitreal triamcinolone for refractory cystoid macular oedema secondary to birdshot retinochoroidopathy. Arch Ophthalmol 2001; 119: 1380\u20131383.","journal-title":"Arch Ophthalmol"},{"key":"BF6701395_CR13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1046\/j.1442-9071.2001.00360.x","volume":"29","author":"S Young","year":"2001","unstructured":"Young S, Larkin G, Branley M, Lightman S . Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitis. Clin Exp Ophthalmol 2001; 29: 2\u20136.","journal-title":"Clin Exp Ophthalmol"},{"key":"BF6701395_CR14","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1136\/bjo.87.3.361","volume":"87","author":"RF Degenring","year":"2003","unstructured":"Degenring RF, Jonas JB . Intravitreal injection of triamcinolone acetonide as treatment of chronic uveitis. Br J Ophthalmol 2003; 87: 361.","journal-title":"Br J Ophthalmol"},{"key":"BF6701395_CR15","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1136\/bjo.87.8.1010","volume":"87","author":"KH Sonoda","year":"2003","unstructured":"Sonoda KH, Enaida H, Ueno A, Nakamura T, Kawano YI, Kubota T et al. Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study. Br J Ophthalmol 2003; 87: 1010\u20131014.","journal-title":"Br J Ophthalmol"},{"key":"BF6701395_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S0002-9394(02)01938-4","volume":"135","author":"N Benhamou","year":"2003","unstructured":"Benhamou N, Massin P, Haouchine B, Audren F, Tadayoni R, Gaudric A . Intravitreal triamcinolone for refractory pseudophakic macular oedema. Am J Ophthalmol 2003; 135: 246\u2013249.","journal-title":"Am J Ophthalmol"},{"key":"BF6701395_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0886-3350(02)01441-4","volume":"29","author":"MD Conway","year":"2003","unstructured":"Conway MD, Canakis C, Livir-Rallatos C, Peyman GA . Intravitreal triamcinolone acetonide for refractory chronic pseudophakic cystoid macular oedema. J Cataract Refract Surg 2003; 29: 27\u201333.","journal-title":"J Cataract Refract Surg"},{"key":"BF6701395_CR18","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/S0002-9394(03)00230-7","volume":"136","author":"JB Jonas","year":"2003","unstructured":"Jonas JB, Kreissig I, Degenring RF . Intravitreal triamcinolone acetonide for pseudophakic cystoid macular oedema. Am J Ophthalmol 2003; 136: 384\u2013386.","journal-title":"Am J Ophthalmol"},{"key":"BF6701395_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1442-9071.1995.tb00179.x","volume":"23","author":"P Penfold","year":"1995","unstructured":"Penfold P, Gyory J, Hunyor A, Billson FA . Exudative macular degeneration and intravitreal triamcinolone. A pilot study. Aust NZ J Ophthalmol 1995; 23: 293\u2013298.","journal-title":"Aust NZ J Ophthalmol"},{"key":"BF6701395_CR20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/00006982-200003000-00004","volume":"20","author":"RP Danis","year":"2000","unstructured":"Danis RP, Ciulla TA, Pratt LM, Anliker W . Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000; 20: 244\u2013250.","journal-title":"Retina"},{"key":"BF6701395_CR21","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1001\/archopht.121.5.667","volume":"121","author":"MC Gillies","year":"2003","unstructured":"Gillies MC, Simpson JM, Luo W, Penfold P, Hunyor AB, Chua W et al. A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results. Arch Ophthalmol 2003; 121: 667\u2013673.","journal-title":"Arch Ophthalmol"},{"key":"BF6701395_CR22","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1016\/S0161-6420(03)00544-X","volume":"110","author":"RF Spaide","year":"2003","unstructured":"Spaide RF, Sorenson J, Maranan L . Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2003; 110: 1517\u20131525.","journal-title":"Ophthalmology"},{"key":"BF6701395_CR23","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s00417-002-0547-y","volume":"240","author":"JB Jonas","year":"2002","unstructured":"Jonas JB, Kreissig I, Degenring RF . Repeated intravitreal injections of triamcinolone acetonide as treatment of progressive exudative age-related macular degeneration. Brief Report. Graef Arch Clin Exp Ophthalmol 2002; 240: 872\u2013873.","journal-title":"Graef Arch Clin Exp Ophthalmol"},{"key":"BF6701395_CR24","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1136\/bjo.87.4.462","volume":"87","author":"JB Jonas","year":"2003","unstructured":"Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R . Intravitreal triamcinolone acetonide for exudative age-related macular degeneration. Br J Ophthalmol 2003; 87: 462\u2013468.","journal-title":"Br J Ophthalmol"},{"key":"BF6701395_CR25","doi-asserted-by":"crossref","unstructured":"Jonas JB, Akkoyun I, Budde WM, Kreissig I, Degenring RF . Intravitreal re-injection of triamcinolone for exudative age-related macular degeneration. Arch Ophthalmol 2004, (in print).","DOI":"10.1001\/archopht.122.2.218"},{"key":"BF6701395_CR26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3928\/1542-8877-20030901-11","volume":"34","author":"VS Saraiva","year":"2003","unstructured":"Saraiva VS, Sallum JM, Farah ME . Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide. Ophthalmic Surg Lasers Imaging 2003; 34: 398\u2013400.","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"BF6701395_CR27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1177\/112067210301300611","volume":"13","author":"JB Jonas","year":"2003","unstructured":"Jonas JB, Kreissig I, Degenring RF . Intravitreal triamcinolone as treatment for ischaemic ophthalmopathy. Eur J Ophthalmol 2003; 13: 575\u2013576.","journal-title":"Eur J Ophthalmol"},{"key":"BF6701395_CR28","doi-asserted-by":"crossref","unstructured":"Jonas JB . Intravitreal triamcinolone acetonide for treatment of sympathetic ophthalmia. Am J Ophthalmol 2004, (in print).","DOI":"10.1016\/S0002-9394(03)00899-7"},{"key":"BF6701395_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00006982-200302000-00022","volume":"23","author":"CD Alldredge","year":"2003","unstructured":"Alldredge CD, Garretson BR . Intravitreal triamcinolone for the treatment of idiopathic juxtafoveal telangiectasis. Retina 2003; 23: 113\u2013116.","journal-title":"Retina"},{"key":"BF6701395_CR30","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/00006982-200005000-00024","volume":"20","author":"GA Peyman","year":"2000","unstructured":"Peyman GA, Cheema R, Conway MD, Fang T . Triamcinolone acetonide as an aid to visualization of the vitreous and the posterior hyaloid during pars plana vitrectomy. Retina 2000; 20: 554\u2013555.","journal-title":"Retina"},{"key":"BF6701395_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0002-9394(03)00389-1","volume":"136","author":"E Rechtman","year":"2003","unstructured":"Rechtman E, Allen VD, Danis RP, Pratt LM, Harris A, Speicher MA . Intravitreal triamcinolone for choroidal neovascularization in ocular histoplasmosis syndrome. Am J Ophthalmol 2003; 136: 739\u2013741.","journal-title":"Am J Ophthalmol"},{"key":"BF6701395_CR32","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0002-9394(03)00266-6","volume":"136","author":"IU Scott","year":"2003","unstructured":"Scott IU, Flynn HW, Rosenfeld PJ . Intravitreal triamcinolone acetonide for idiopathic cystoid macular edema. Am J Ophthalmol 2003; 136: 737\u2013739.","journal-title":"Am J Ophthalmol"},{"key":"BF6701395_CR33","doi-asserted-by":"crossref","unstructured":"Jonas JB, Kreissig I, Degenring RF . Cataract surgery after intravitreal injection of triamcinolone acetonide. Eye 2004, (in print).","DOI":"10.1038\/sj.eye.6700654"},{"key":"BF6701395_CR34","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00417-003-0719-4","volume":"241","author":"JB Jonas","year":"2003","unstructured":"Jonas JB . Intravitreal triamcinolone acetonide as treatment of chronic focal immunologic corneal graft reaction. Brief Report. Graef Arch Clin Exp Ophthalmol 2003; 241: 779\u2013780.","journal-title":"Graef Arch Clin Exp Ophthalmol"},{"key":"BF6701395_CR35","doi-asserted-by":"crossref","unstructured":"Jonas JB . Intravitreal triamcinolone acetonide as treatment for extensive exudative retinal detachment? Br J Ophthalmol 2004, (in print).","DOI":"10.1136\/bjo.2003.028688"},{"key":"BF6701395_CR36","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1034\/j.1600-0420.2003.00130.x","volume":"81","author":"JB Jonas","year":"2003","unstructured":"Jonas JB, Kreissig I, Degenring RF . Neovascular glaucoma treated by intravitreal triamcinolone acetonide. Acta Ophthalmol 2003; 81: 540\u2013541.","journal-title":"Acta Ophthalmol"},{"key":"BF6701395_CR37","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1136\/bjo.86.9.1066","volume":"86","author":"JB Jonas","year":"2002","unstructured":"Jonas JB . Concentration of intravitreally applicated triamcinolone acetonide in aqueous humour. Br J Ophthalmol 2002; 86: 1066.","journal-title":"Br J Ophthalmol"},{"key":"BF6701395_CR38","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1136\/bjo.86.12.1450-a","volume":"86","author":"JB Jonas","year":"2002","unstructured":"Jonas JB . Concentration of intravitreally injected triamcinolone acetonide in intraocular silicone oil. Br J Ophthalmol 2002; 86: 1450\u20131451.","journal-title":"Br J Ophthalmol"},{"key":"BF6701395_CR39","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0161-6420(02)01969-3","volume":"110","author":"PM Beer","year":"2003","unstructured":"Beer PM, Bakri SJ, Singh RJ, Liu W, Peters III GB, Miller M . Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003; 110: 681\u2013686.","journal-title":"Ophthalmology"},{"key":"BF6701395_CR40","doi-asserted-by":"crossref","unstructured":"Jonas JB . Intraocular availability of triamcinolone acetonide after intravitreal injection. Am J Ophthalmol 2004, (in print).","DOI":"10.1016\/j.ajo.2003.08.012"},{"key":"BF6701395_CR41","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1046\/j.1440-1606.1999.00238.x","volume":"27","author":"RJ Wingate","year":"1999","unstructured":"Wingate RJ, Beaumont PE . Intravitreal triamcinolone and elevated intraocular pressure. Aust N Z J Ophthalmol 1999; 27: 431\u2013432.","journal-title":"Aust N Z J Ophthalmol"},{"key":"BF6701395_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1136\/bjo.87.1.24","volume":"87","author":"JB Jonas","year":"2003","unstructured":"Jonas JB, Kreissig I, Degenring R . Intraocular pressure after intravitreal injection of triamcinolone acetonide. Br J Ophthalmol 2003; 87: 24\u201327.","journal-title":"Br J Ophthalmol"},{"key":"BF6701395_CR43","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3928\/1542-8877-20030901-08","volume":"34","author":"SJ Bakri","year":"2003","unstructured":"Bakri SJ, Beer PM . The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers Imaging 2003; 34: 386\u2013390.","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"BF6701395_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/archopht.121.2.271","volume":"121","author":"MS Benz","year":"2003","unstructured":"Benz MS, Murray TG, Dubovy SR, Katz RS, Eifrig CW . Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone. Arch Ophthalmol 2003; 121: 271\u2013273.","journal-title":"Arch Ophthalmol"},{"key":"BF6701395_CR45","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1001\/archopht.121.11.1663-a","volume":"121","author":"JB Jonas","year":"2003","unstructured":"Jonas JB, Kreissig I, Degenring RF . Endophthalmitis after intravitreal injection of triamcinolone acetonide. Arch Ophthalmol 2003; 121: 1663\u20131664.","journal-title":"Arch Ophthalmol"},{"key":"BF6701395_CR46","doi-asserted-by":"crossref","unstructured":"Jonas JB, Bleyl U . Morphallaxia-like ocular histology after intravitreal triamcinolone acetonide. Br J Ophthalmol 2004, (in print).","DOI":"10.1136\/bjo.2003.034140"},{"key":"BF6701395_CR47","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1001\/archopht.1985.01050050100026","volume":"103","author":"T Ishibashi","year":"1985","unstructured":"Ishibashi T, Miki K, Sorgente N, Patterson R, Ryan SJ . Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol 1985; 103: 708\u2013711.","journal-title":"Arch Ophthalmol"},{"key":"BF6701395_CR48","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1001\/archopht.1992.01080200135041","volume":"110","author":"CA Wilson","year":"1992","unstructured":"Wilson CA, Berkowitz BA, Sato Y, Ando N, Handa JT, de Juan Jr E . Treatment with intravitreal steroid reduces blood\u2013retinal barrier breakdown due to retinal photocoagulation. Arch Ophthalmol 1992; 110: 1155\u20131159.","journal-title":"Arch Ophthalmol"},{"key":"BF6701395_CR49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/BF01681698","volume":"231","author":"AN Antoszyk","year":"1993","unstructured":"Antoszyk AN, Gottlieb JL, Machemer R, Hatchell DL . The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization. Graefes Arch Clin Exp Ophthalmol 1993; 231: 34\u201340.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BF6701395_CR50","first-page":"3125","volume":"43","author":"PL Penfold","year":"2002","unstructured":"Penfold PL, Wen L, Madigan MC, King NJ, Provis JM . Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells. Invest Ophthalmol Vis Sci 2002; 43: 3125\u20133130.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF6701395_CR51","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1046\/j.1442-9071.2001.00407.x","volume":"29","author":"PL Penfold","year":"2001","unstructured":"Penfold PL, Wong JG, Gyory J, Billson FA . Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC-II in exudative age-related macular degeneration. Clin Exp Ophthalmol 2001; 29: 188\u2013192.","journal-title":"Clin Exp Ophthalmol"},{"key":"BF6701395_CR52","first-page":"3125","volume":"43","author":"PL Penfold","year":"2002","unstructured":"Penfold PL, Wen L, Madigan MC, Gillies MC, King NJ, Provis JM . Modulation of permeability and adhesion molecule expression by human choroidal endothelial cells. Invest Ophthalmol Vis Sci 2002; 43: 3125\u20133130.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF6701395_CR53","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/0002-9394(81)90013-1","volume":"91","author":"BW McCuen II","year":"1981","unstructured":"McCuen II BW, Bessler M, Tano Y, Chandler D, Machemer R . The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol 1981; 91: 785\u2013788.","journal-title":"Am J Ophthalmol"},{"key":"BF6701395_CR54","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/0002-9394(86)90593-3","volume":"101","author":"T Hida","year":"1986","unstructured":"Hida T, Chandler D, Arena JE, Machemer R . Experimental and clinical observations of the intraocular toxicity of commercial corticosteroid preparations. Am J Ophthalmol 1986; 101: 190\u2013195.","journal-title":"Am J Ophthalmol"},{"key":"BF6701395_CR55","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/archopht.1992.01080140115038","volume":"110","author":"HW Kwak","year":"1992","unstructured":"Kwak HW, D\u2019Amico DJ . Evaluation of the retinal toxicity and pharmacokinetics of dexamethasone after intravitreal injection. Arch Ophthalmol 1992; 110: 259\u2013266.","journal-title":"Arch Ophthalmol"},{"key":"BF6701395_CR56","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3928\/1542-8877-20001101-07","volume":"31","author":"M Kivilcim","year":"2000","unstructured":"Kivilcim M, Peyman GA, El-Dessouky ES, Kazi AA, Cheema R, Hegazy H . Retinal toxicity of triamcinolone acetonide in silicone-filled eyes. Ophthalmic Surg Lasers 2000; 31: 474\u2013478.","journal-title":"Ophthalmic Surg Lasers"},{"key":"BF6701395_CR57","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1034\/j.1600-0420.2003.00176.x","volume":"81","author":"RF Degenring","year":"2003","unstructured":"Degenring RF, Kamppeter B, Kreissig I, Jonas JB . Morphologic and functional changes after intravitreal triamcinolone acetonide for retinal vein occlusion. Acta Ophthalmol 2003; 81: 548\u2013550.","journal-title":"Acta Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6701395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701395","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6701395.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:16:25Z","timestamp":1684412185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6701395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,23]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["BF6701395"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6701395","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4,23]]}}}